1225 related articles for article (PubMed ID: 26588055)
1. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
2. Dynamically decreased miR-671-5p expression is associated with oncogenic transformation and radiochemoresistance in breast cancer.
Tan X; Li Z; Ren S; Rezaei K; Pan Q; Goldstein AT; Macri CJ; Cao D; Brem RF; Fu SW
Breast Cancer Res; 2019 Aug; 21(1):89. PubMed ID: 31391072
[TBL] [Abstract][Full Text] [Related]
3. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
[TBL] [Abstract][Full Text] [Related]
4. The Effect of LncRNA H19/miR-194-5p Axis on the Epithelial-Mesenchymal Transition of Colorectal Adenocarcinoma.
Li CF; Li YC; Wang Y; Sun LB
Cell Physiol Biochem; 2018; 50(1):196-213. PubMed ID: 30278464
[TBL] [Abstract][Full Text] [Related]
5. miR-204 inhibits invasion and epithelial-mesenchymal transition by targeting FOXM1 in esophageal cancer.
Sun Y; Yu X; Bai Q
Int J Clin Exp Pathol; 2015; 8(10):12775-83. PubMed ID: 26722467
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer.
Yu Y; Zhao Y; Sun XH; Ge J; Zhang B; Wang X; Cao XC
Oncotarget; 2015 Oct; 6(33):34423-36. PubMed ID: 26460733
[TBL] [Abstract][Full Text] [Related]
8. miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells.
Li J; Wang Y; Luo J; Fu Z; Ying J; Yu Y; Yu W
FEBS Lett; 2012 Oct; 586(20):3761-5. PubMed ID: 23010597
[TBL] [Abstract][Full Text] [Related]
9. miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer.
Tan X; Peng J; Fu Y; An S; Rezaei K; Tabbara S; Teal CB; Man YG; Brem RF; Fu SW
Breast Cancer Res; 2014 Sep; 16(5):435. PubMed ID: 25228385
[TBL] [Abstract][Full Text] [Related]
10. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
11. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
Kong X; Ding X; Li X; Gao S; Yang Q
Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.
Liu X; Xie T; Mao X; Xue L; Chu X; Chen L
Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661
[TBL] [Abstract][Full Text] [Related]
13. MiR-204-5p/Six1 feedback loop promotes epithelial-mesenchymal transition in breast cancer.
Zeng J; Wei M; Shi R; Cai C; Liu X; Li T; Ma W
Tumour Biol; 2016 Feb; 37(2):2729-35. PubMed ID: 26408179
[TBL] [Abstract][Full Text] [Related]
14. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
15. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.
Wierstra I
Adv Cancer Res; 2013; 119():191-419. PubMed ID: 23870513
[TBL] [Abstract][Full Text] [Related]
16. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
Sun LL; Wang J; Zhao ZJ; Liu N; Wang AL; Ren HY; Yang F; Diao KX; Fu WN; Wan EH; Mi XY
Oncol Rep; 2014 May; 31(5):2085-92. PubMed ID: 24677135
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1.
Zhao C; Ling X; Li X; Hou X; Zhao D
Breast Cancer; 2019 Nov; 26(6):817-825. PubMed ID: 31243644
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.
Shen Y; Ye YF; Ruan LW; Bao L; Wu MW; Zhou Y
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252173
[TBL] [Abstract][Full Text] [Related]
19. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-139-5p affects cisplatin sensitivity in human nasopharyngeal carcinoma cells by regulating the epithelial-to-mesenchymal transition.
Shao Q; Zhang P; Ma Y; Lu Z; Meng J; Li H; Wang X; Chen D; Zhang M; Han Y; Liu H; Ma S
Gene; 2018 Apr; 652():48-58. PubMed ID: 29427737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
